Ameritas Advisory Services’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59K | Buy |
+437
| New | +$1.59K | ﹤0.01% | 2542 |
|
|
2024
Q2 | – | Sell |
-12,096
| Closed | -$15.7K | – | 899 |
|
|
2024
Q1 | $15.7K | Buy |
+12,096
| New | +$15.7K | ﹤0.01% | 869 |
|
|
2023
Q4 | – | Sell |
-12,096
| Closed | -$10.5K | – | 677 |
|
|
2023
Q3 | $10.5K | Hold |
12,096
| – | – | ﹤0.01% | 802 |
|
|
2023
Q2 | $12.3K | Buy |
+12,096
| New | +$12.3K | ﹤0.01% | 550 |
|